Transactions
Peterson & Co. acts for Revive Therapeutics Ltd. in Rights Offering
On May 16, 2016, Revive Therapeutics Ltd. (TSXV: RVV) announced a best efforts rights offering to raise $2.2 million. Revive is focused on commercializing treatments for gout, and rare diseases such as cystinuria, Wilson’s disease and Rett syndrome.
Recent Transactions
Peterson McVicar Acts for Revival Gold to Acquire Ensign Minerals and Concurrent C$7 Million Equity Financing
Peterson McVicar Acts for Red Cloud in Kootenay Silver Public Offering for Gross Proceeds of Up to C$5.0 Million
Peterson McVicar Acts for Bitfarms in $375M At-the-Market Equity Offering Program
Peterson McVicar Acts for Red Cloud in Blackrock Silver $5.0M Bought Deal Financing